We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$3.85B
AUM Growth
+$538M
Cap. Flow
+$255M
Cap. Flow %
6.63%
Top 10 Hldgs %
8.75%
Holding
1,265
New
117
Increased
828
Reduced
245
Closed
63

Sector Composition

Rank Sector Weight
1 Technology 28.89%
2 Healthcare 14.73%
3 Industrials 11.24%
4 Energy 9.78%
5 Consumer Discretionary 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSRM icon
1126
SSR Mining
SSRM
$6.4B
$207K 0.01%
11,678
-4,224
-27% -$72.3K
KL
1127
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$207K 0.01%
+4,929
New +$208K
EGO icon
1128
Eldorado Gold
EGO
$10.2B
$206K 0.01%
21,949
+8,719
+66% +$80.5K
LVS icon
1129
Las Vegas Sands
LVS
$29.4B
$206K 0.01%
+5,448
New +$209K
MYGN icon
1130
Myriad Genetics
MYGN
$311M
$204K 0.01%
+7,374
New +$214K
EQH icon
1131
Equitable Holdings
EQH
$14.4B
$203K 0.01%
+6,214
New +$204K
RLJ icon
1132
RLJ Lodging Trust
RLJ
$1.67B
$200K 0.01%
14,280
+1,704
+14% +$24K
AZRE
1133
DELISTED
Azure Power Global Limited
AZRE
$200K 0.01%
+11,029
New +$233K
SOL
1134
DELISTED
Emeren Group
SOL
$195K 0.01%
32,817
+13,061
+66% +$93.4K
CGAU
1135
Centerra Gold
CGAU
$4.17B
$192K 0.01%
24,867
+9,954
+67% +$75.7K
DBRG icon
1136
DigitalBridge
DBRG
$2.95B
$192K 0.01%
5,763
+231
+4% +$6.87K
BVS icon
1137
Bioventus
BVS
$1.17B
$191K 0.01%
+13,167
New +$187K
ONEM
1138
DELISTED
1Life Healthcare
ONEM
$187K ﹤0.01%
+10,640
New +$206K
TTCF
1139
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$186K ﹤0.01%
+11,991
New +$205K
OR icon
1140
OR Royalties Inc
OR
$6.32B
$185K ﹤0.01%
+15,115
New +$184K
NXGN
1141
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$185K ﹤0.01%
+10,412
New +$167K
PSNL icon
1142
Personalis
PSNL
$1.55B
$183K ﹤0.01%
+12,818
New +$214K
SAND
1143
DELISTED
Sandstorm Gold
SAND
$183K ﹤0.01%
29,507
+11,799
+67% +$73.8K
AUY
1144
DELISTED
Yamana Gold, Inc.
AUY
$181K ﹤0.01%
43,021
+17,234
+67% +$71.4K
RAAS
1145
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
$180K ﹤0.01%
20,739
+2,032
+11% +$23K
ZEPP
1146
Zepp Health
ZEPP
$76.1M
$179K ﹤0.01%
+8,884
New +$266K
AHRT
1147
AH Realty Trust
AHRT
$503M
$176K ﹤0.01%
11,551
+139
+1% +$2K
CLLS
1148
Cellectis
CLLS
$278M
$175K ﹤0.01%
+21,529
New +$212K
FOLD
1149
DELISTED
Amicus Therapeutics
FOLD
$175K ﹤0.01%
+15,114
New +$168K
CPLG
1150
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$175K ﹤0.01%
11,123
+134
+1% +$2.11K

Similar funds

Vident Investment Advisory's Q4 2021 Portfolio in Review

As of Q4 2021, Vident Investment Advisory held 1,265 positions worth $3.85B, up 16% from $3.31B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Vident Investment Advisory deployed $255M of net new capital in Q4 2021, opening 117 new positions and adding to 828 existing holdings. Its largest new stake was Vicarious Surgical: 35,777 shares worth $11.4M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was iRhythm Holdings, an estimated $27.4M trimmed.

  • Vident Investment Advisory's largest Q4 2021 buy was Vicarious Surgical: 35,777 shares worth $11.4M.
  • Vident Investment Advisory added most to 3D Systems Corp in Q4 2021, an estimated $9.25M increase.
  • Vident Investment Advisory's biggest Q4 2021 reduction was iRhythm Holdings, cutting an estimated $27.4M.
  • Vident Investment Advisory fully exited Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island) in Q4 2021, selling an estimated $27.4M.
  • Vident Investment Advisory's ten largest holdings make up 8.7% of its $3.85B portfolio in Q4 2021.
  • Vident Investment Advisory opened 117 new positions and closed 63 in Q4 2021.
  • Vident Investment Advisory's portfolio value rose 16% quarter-over-quarter to $3.85B.

Based on Vident Investment Advisory's 13F filing for Q4 2021, filed 14 Feb 2022.